Xcout Intel
Auxilium Health competitors & alternatives
The 12 closest competitors and alternatives to Auxilium Health among healthcare companies — ranked by similarity to what Auxilium Health actually does, not by market-cap band.
Subscribe to see Auxilium Health’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Auxilium Health
Auxilium Health is an Ontario-based company that develops biomaterials combining therapeutics and diagnostics. Its mission is to assist patients in healing more effectively through advanced medical technology.
Auxilium Health at a glance
Auxilium Health is a healthcare company headquartered in United States. It has raised at least $6.4M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round, Seed, raised $3.4M in July 2026. Xcout tracks 4 named people at Auxilium Health, including Isaiah Kaiser (Founder and CEO).
Auxilium Health leadership
- Isaiah KaiserFounder and CEO
- Isaiah KaiserExecutive Officer
- Duane ManciniDirector
- William MorgensternDirector
Auxilium Health funding rounds
At least $6.4M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.4M | — | |
| Seed | $3M | — | |
| Pre-Seed | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Auxilium Health news
Top 12 Auxilium Health competitors
Ranked by semantic similarity — how close each company is to Auxilium Health by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Health Care
S2Medical AB is a Swedish biomed-tech company that develops products and technologies for wound healing, infection control, and cosmeceuticals. The company utilizes biomaterials, regenerative medicine, and antimicrobial peptides to create solutions such as negative pressure therapy systems and treatments for multi-resistant bacterial infections, serving patients and healthcare providers.
Similar healthcare company
Healome Therapeutics is an eye care therapeutics company headquartered in Birmingham, United Kingdom. The company focuses on developing more effective, safer, and practical treatments for vision-threatening ocular surface diseases.
Healthcare Services
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids. Additionally, CT-101 functions as a tissue healing accelerant, offering potential for treating androgenetic alopecia and persistent chronic wounds. Established in 2008, the company maintains its headquarters in Pittsburgh, Pennsylvania.
Similar healthcare company
Avadim Health, Inc. is a high-growth life sciences, healthcare, and wellness company based in Asheville, North Carolina. The firm develops and sells targeted topical products designed to improve immune health, neuromuscular health, and skin barrier function.
BioTech
Spiderwort Biotechnologies Inc. is an Ottawa-based biotechnology innovator specializing in all-natural, plant-based biomaterials designed to support tissue regeneration and repair spinal cord injuries.
Biotech
AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Biotechnology
Amplicore Inc. develops injectable therapeutics aimed at treating degenerative musculoskeletal disorders such as osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. The company focuses on regenerative and minimally invasive approaches to address the underlying causes of joint discomfort and restore mobility for patients.
Pharmaceuticals
Auxilius Pharma is a privately held pharmaceutical and biotechnology research start-up headquartered in Warsaw, Poland, that focuses on optimizing and further developing well-established medicines.
Biotechnology
Autonomy Bio Inc. is a biotechnology company focused on developing human aging therapeutics aimed at extending healthspan and mitigating age-related decline. The company targets individuals seeking to maintain health and independence as they age.
Biotech
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. Its lead product, ExoPTEN, has demonstrated strong preclinical data supporting clinical potential in treating acute spinal cord and optic nerve injury. The company was founded on June 27, 2011 and is headquartered in Toronto, Canada.
Biotechnology
Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing innovative therapeutic agents. Its foundation lies in a unique signal peptide-based platform, which it leverages to address critical health challenges, specifically infectious diseases and various cancers. The company's primary therapeutic candidate, ImMucin, has successfully advanced through Phase I/II clinical trials as a potential treatment for multiple myeloma. Beyond ImMucin, Vaxil Bio is actively developing a vaccine/treatment for tuberculosis, as well as a vaccine targeting coronavirus (COVID-19). Strategic alliances bolster its research efforts; Vaxil Bio collaborates with The Tel Aviv Sourasky Medical Center on a research initiative to create a peptide-based COVID-19 vaccine. Furthermore, it holds a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases to assess CorVax's efficacy in preventing COVID-19 in murine models. Established in 2006, the company's operations are based in Toronto, Canada.
Biotechnology
Aurion Biotech Inc. develops regenerative cell therapies for ophthalmology, focusing on treatments for corneal endothelial disease and vision loss. Its lead product, AURN001, is a combination therapy utilizing human corneal endothelial cells designed to restore corneal clarity and provide a minimally invasive alternative to traditional donor tissue transplantation. The company serves patients suffering from blindness and provides advanced treatment options for ophthalmologists.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Auxilium Health and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Auxilium Healthand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →